These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28873458)

  • 1. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
    PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats.
    Silva FMO; Costalonga EC; Silva C; Carreira ACO; Gomes SA; Sogayar MC; Fanelli C; Noronha IL
    Mol Med; 2019 Aug; 25(1):41. PubMed ID: 31455237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of infiltrating macrophages in high glucose-induced peritoneal fibrosis in rats.
    Hu W; Jiang Z; Zhang Y; Liu Q; Fan J; Luo N; Dong X; Yu X
    Mol Med Rep; 2012 Jul; 6(1):93-9. PubMed ID: 22552745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model.
    Yoshimine H; Tanoue S; Ibi Y; Minami M; Nakahara M; Tokunaga K; Kanmura S; Ido A
    Clin Exp Nephrol; 2021 Sep; 25(9):935-943. PubMed ID: 33909175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats.
    Silva FMO; Carvalho PO; Costalonga EC; Pepineli R; Maranhão RC; Noronha IL
    PLoS One; 2022; 17(5):e0268197. PubMed ID: 35522621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.
    Sakai N; Nakamura M; Lipson KE; Miyake T; Kamikawa Y; Sagara A; Shinozaki Y; Kitajima S; Toyama T; Hara A; Iwata Y; Shimizu M; Furuichi K; Kaneko S; Tager AM; Wada T
    Sci Rep; 2017 Jul; 7(1):5392. PubMed ID: 28710437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 promotes the progression of peritoneal fibrosis through the activation of the TGF-β/Smad signaling pathway: An in vitro and in vivo study.
    Ma YL; Chen F; Yang SX; Chen BP; Shi J
    Int J Mol Med; 2018 Feb; 41(2):1030-1038. PubMed ID: 29207016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
    Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
    BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
    Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
    Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of epimorphin in a peritoneal fibrosis mouse model.
    Yamada M; Hirai Y; Inoue D; Komatsu S; Uchida T; Kojima T; Tomiyasu T; Yoshikawa N; Oda T
    Perit Dial Int; 2022 Sep; 42(5):522-529. PubMed ID: 34641723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-Derived Mesenchymal Stem Cells Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats.
    Costalonga EC; Fanelli C; Garnica MR; Noronha IL
    Stem Cells Int; 2020; 2020():3768718. PubMed ID: 32565826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin inhibits the development and progression of peritoneal fibrosis.
    Xiong C; Liu N; Fang L; Zhuang S; Yan H
    J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
    Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
    Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
    Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
    Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
    Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
    Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.